APO Research
Talk to an analyst

APO RESEARCH · REPORT

Heparin Sodium Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Heparin Sodium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchHeparin Sodium Injection Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Heparin Sodium Injection Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Heparin Sodium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Heparin Sodium Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Heparin Sodium Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Heparin Sodium Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Heparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Heparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Heparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Heparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Heparin Sodium Injection include Sichuan Deebio, Shenzhen Hepalink, Nanjing King-friend, Pfizer, Changzhou Qianhong Bio-pharma, Baxter, Yino Pharma Limited, Xinbai Pharmaceuticals and Pharma Action, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Heparin Sodium Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Heparin Sodium Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Heparin Sodium Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Heparin Sodium Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Heparin Sodium Injection Segment by Company

Sichuan Deebio

Shenzhen Hepalink

Nanjing King-friend

Pfizer

Changzhou Qianhong Bio-pharma

Baxter

Yino Pharma Limited

Xinbai Pharmaceuticals

Pharma Action

Opocrin

Dongying Tiandong Pharmaceutical

Dongcheng Biochemicals

Changshan Biochemical

Bioibérica

Aspen Oss

Heparin Sodium Injection Segment by Type

1, 000 USP Units / mL

5, 000 USP Units / mL

10, 000 USP Units / mL

Heparin Sodium Injection Segment by Application

Cardioversion of Atrial Fibrillation/Flutter

Complications of Pregnancy

Treatment of Venous Thromboembolism

Other

Heparin Sodium Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Heparin Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin Sodium Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Heparin Sodium Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Heparin Sodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Heparin Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Heparin Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Heparin Sodium Injection Industry Trends Table 2. Heparin Sodium Injection Industry Drivers Table 3. Heparin Sodium Injection Industry Opportunities and Challenges Table 4. Heparin Sodium Injection Industry Restraints Table 5. Global Heparin Sodium Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Heparin Sodium Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Heparin Sodium Injection Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Heparin Sodium Injection Sales Market Share by Manufacturers Table 9. Global Heparin Sodium Injection Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Heparin Sodium Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Heparin Sodium Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Heparin Sodium Injection Manufacturers, Product Type & Application Table 13. Global Heparin Sodium Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Heparin Sodium Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1, 000 USP Units / mL Table 17. Major Manufacturers of 5, 000 USP Units / mL Table 18. Major Manufacturers of 10, 000 USP Units / mL Table 19. Global Heparin Sodium Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Heparin Sodium Injection Sales by Type (2021-2026) & (k units) Table 21. Global Heparin Sodium Injection Sales by Type (2027-2032) & (k units) Table 22. Global Heparin Sodium Injection Sales Market Share by Type (2021-2026) Table 23. Global Heparin Sodium Injection Sales Market Share by Type (2027-2032) Table 24. Global Heparin Sodium Injection Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Heparin Sodium Injection Revenue by Type (2021-2026) & (k units) Table 26. Global Heparin Sodium Injection Revenue by Type (2027-2032) & (k units) Table 27. Global Heparin Sodium Injection Revenue Market Share by Type (2021-2026) Table 28. Global Heparin Sodium Injection Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Cardioversion of Atrial Fibrillation/Flutter Table 30. Major Manufacturers of Complications of Pregnancy Table 31. Major Manufacturers of Treatment of Venous Thromboembolism Table 32. Major Manufacturers of Other Table 33. Global Heparin Sodium Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Heparin Sodium Injection Sales by Application (2021-2026) & (k units) Table 35. Global Heparin Sodium Injection Sales by Application (2027-2032) & (k units) Table 36. Global Heparin Sodium Injection Sales Market Share by Application (2021-2026) Table 37. Global Heparin Sodium Injection Sales Market Share by Application (2027-2032) Table 38. Global Heparin Sodium Injection Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Heparin Sodium Injection Revenue by Application (2021-2026) & (k units) Table 40. Global Heparin Sodium Injection Revenue by Application (2027-2032) & (k units) Table 41. Global Heparin Sodium Injection Revenue Market Share by Application (2021-2026) Table 42. Global Heparin Sodium Injection Revenue Market Share by Application (2027-2032) Table 43. Global Heparin Sodium Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Heparin Sodium Injection Sales by Region (2021-2026) & (k units) Table 45. Global Heparin Sodium Injection Sales Market Share by Region (2021-2026) Table 46. Global Heparin Sodium Injection Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Heparin Sodium Injection Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Heparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 50. North America Heparin Sodium Injection Sales by Country (2027-2032) & (k units) Table 51. Europe Heparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 53. Europe Heparin Sodium Injection Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Heparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Heparin Sodium Injection Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Heparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Heparin Sodium Injection Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Heparin Sodium Injection Sales by Country (2027-2032) & (k units) Table 60. Global Heparin Sodium Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Heparin Sodium Injection Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Heparin Sodium Injection Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Heparin Sodium Injection Revenue Market Share by Region (2021-2026) Table 64. Global Heparin Sodium Injection Revenue Market Share by Region (2027-2032) Table 65. Sichuan Deebio Company Information Table 66. Sichuan Deebio Business Overview Table 67. Sichuan Deebio Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Sichuan Deebio Heparin Sodium Injection Product Portfolio Table 69. Sichuan Deebio Recent Development Table 70. Shenzhen Hepalink Company Information Table 71. Shenzhen Hepalink Business Overview Table 72. Shenzhen Hepalink Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Shenzhen Hepalink Heparin Sodium Injection Product Portfolio Table 74. Shenzhen Hepalink Recent Development Table 75. Nanjing King-friend Company Information Table 76. Nanjing King-friend Business Overview Table 77. Nanjing King-friend Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Nanjing King-friend Heparin Sodium Injection Product Portfolio Table 79. Nanjing King-friend Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Pfizer Heparin Sodium Injection Product Portfolio Table 84. Pfizer Recent Development Table 85. Changzhou Qianhong Bio-pharma Company Information Table 86. Changzhou Qianhong Bio-pharma Business Overview Table 87. Changzhou Qianhong Bio-pharma Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Changzhou Qianhong Bio-pharma Heparin Sodium Injection Product Portfolio Table 89. Changzhou Qianhong Bio-pharma Recent Development Table 90. Baxter Company Information Table 91. Baxter Business Overview Table 92. Baxter Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Baxter Heparin Sodium Injection Product Portfolio Table 94. Baxter Recent Development Table 95. Yino Pharma Limited Company Information Table 96. Yino Pharma Limited Business Overview Table 97. Yino Pharma Limited Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Yino Pharma Limited Heparin Sodium Injection Product Portfolio Table 99. Yino Pharma Limited Recent Development Table 100. Xinbai Pharmaceuticals Company Information Table 101. Xinbai Pharmaceuticals Business Overview Table 102. Xinbai Pharmaceuticals Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Xinbai Pharmaceuticals Heparin Sodium Injection Product Portfolio Table 104. Xinbai Pharmaceuticals Recent Development Table 105. Pharma Action Company Information Table 106. Pharma Action Business Overview Table 107. Pharma Action Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Pharma Action Heparin Sodium Injection Product Portfolio Table 109. Pharma Action Recent Development Table 110. Opocrin Company Information Table 111. Opocrin Business Overview Table 112. Opocrin Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Opocrin Heparin Sodium Injection Product Portfolio Table 114. Opocrin Recent Development Table 115. Dongying Tiandong Pharmaceutical Company Information Table 116. Dongying Tiandong Pharmaceutical Business Overview Table 117. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product Portfolio Table 119. Dongying Tiandong Pharmaceutical Recent Development Table 120. Dongcheng Biochemicals Company Information Table 121. Dongcheng Biochemicals Business Overview Table 122. Dongcheng Biochemicals Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Dongcheng Biochemicals Heparin Sodium Injection Product Portfolio Table 124. Dongcheng Biochemicals Recent Development Table 125. Changshan Biochemical Company Information Table 126. Changshan Biochemical Business Overview Table 127. Changshan Biochemical Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Changshan Biochemical Heparin Sodium Injection Product Portfolio Table 129. Changshan Biochemical Recent Development Table 130. Bioibérica Company Information Table 131. Bioibérica Business Overview Table 132. Bioibérica Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Bioibérica Heparin Sodium Injection Product Portfolio Table 134. Bioibérica Recent Development Table 135. Aspen Oss Company Information Table 136. Aspen Oss Business Overview Table 137. Aspen Oss Heparin Sodium Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Aspen Oss Heparin Sodium Injection Product Portfolio Table 139. Aspen Oss Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Heparin Sodium Injection Distributors List Table 143. Heparin Sodium Injection Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Heparin Sodium Injection Product Image Figure 2. Global Heparin Sodium Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Heparin Sodium Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Heparin Sodium Injection Sales (2021-2032) & (k units) Figure 5. Global Heparin Sodium Injection Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Heparin Sodium Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1, 000 USP Units / mL Image Figure 9. 5, 000 USP Units / mL Image Figure 10. 10, 000 USP Units / mL Image Figure 11. Global Heparin Sodium Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Heparin Sodium Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Heparin Sodium Injection Sales Market Share by Type (2021-2032) Figure 14. Global Heparin Sodium Injection Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Heparin Sodium Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Heparin Sodium Injection Revenue Market Share by Type (2021-2032) Figure 17. Cardioversion of Atrial Fibrillation/Flutter Image Figure 18. Complications of Pregnancy Image Figure 19. Treatment of Venous Thromboembolism Image Figure 20. Other Image Figure 21. Global Heparin Sodium Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Heparin Sodium Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Heparin Sodium Injection Sales Market Share by Application (2021-2032) Figure 24. Global Heparin Sodium Injection Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Heparin Sodium Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Heparin Sodium Injection Revenue Market Share by Application (2021-2032) Figure 27. North America Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Heparin Sodium Injection Sales Market Share by Country (2021-2032) Figure 29. U.S. Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Heparin Sodium Injection Sales Market Share by Country (2021-2032) Figure 34. Germany Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Heparin Sodium Injection Sales Market Share by Country (2021-2032) Figure 41. China Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Heparin Sodium Injection Sales Market Share by Country (2021-2032) Figure 49. Brazil Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Heparin Sodium Injection Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Heparin Sodium Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Heparin Sodium Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Heparin Sodium Injection Revenue (2021-2032) & (US$ Million) Figure 60. North America Heparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Heparin Sodium Injection Revenue (2021-2032) & (US$ Million) Figure 62. Europe Heparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Heparin Sodium Injection Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Heparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Heparin Sodium Injection Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Heparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Heparin Sodium Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Heparin Sodium Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 1, 000 USP Units / mL
  • 5, 000 USP Units / mL
  • 10, 000 USP Units / mL
Applications
  • Cardioversion of Atrial Fibrillation/Flutter
  • Complications of Pregnancy
  • Treatment of Venous Thromboembolism
  • Other
Companies covered
  • Sichuan Deebio
  • Shenzhen Hepalink
  • Nanjing King-friend
  • Pfizer
  • Changzhou Qianhong Bio-pharma
  • Baxter
  • Yino Pharma Limited
  • Xinbai Pharmaceuticals
  • Pharma Action
  • Opocrin
  • Dongying Tiandong Pharmaceutical
  • Dongcheng Biochemicals
  • Changshan Biochemical
  • Bioibérica
  • Aspen Oss

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Heparin Sodium Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Heparin Sodium Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Heparin Sodium Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Heparin Sodium Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Heparin Sodium Injection Market Dynamics
  1. 2.1 Heparin Sodium Injection Industry Trends
  2. 2.2 Heparin Sodium Injection Industry Drivers
  3. 2.3 Heparin Sodium Injection Industry Opportunities and Challenges
  4. 2.4 Heparin Sodium Injection Industry Restraints
3 Heparin Sodium Injection Market by Manufacturers
  1. 3.1 Global Heparin Sodium Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Heparin Sodium Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Heparin Sodium Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Heparin Sodium Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Heparin Sodium Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Heparin Sodium Injection Manufacturers, Product Type & Application
  7. 3.7 Global Heparin Sodium Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Heparin Sodium Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Heparin Sodium Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Heparin Sodium Injection Tier 1, Tier 2, and Tier 3
4 Heparin Sodium Injection Market by Type
  1. 4.1 Heparin Sodium Injection Type Introduction
  2. 4.1.1 1, 000 USP Units / mL
  3. 4.1.2 5, 000 USP Units / mL
  4. 4.1.3 10, 000 USP Units / mL
  5. 4.2 Global Heparin Sodium Injection Sales by Type
  6. 4.2.1 Global Heparin Sodium Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Heparin Sodium Injection Sales by Type (2021-2032)
  8. 4.2.3 Global Heparin Sodium Injection Sales Market Share by Type (2021-2032)
  9. 4.3 Global Heparin Sodium Injection Revenue by Type
  10. 4.3.1 Global Heparin Sodium Injection Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Heparin Sodium Injection Revenue by Type (2021-2032)
  12. 4.3.3 Global Heparin Sodium Injection Revenue Market Share by Type (2021-2032)
5 Heparin Sodium Injection Market by Application
  1. 5.1 Heparin Sodium Injection Application Introduction
  2. 5.1.1 Cardioversion of Atrial Fibrillation/Flutter
  3. 5.1.2 Complications of Pregnancy
  4. 5.1.3 Treatment of Venous Thromboembolism
  5. 5.1.4 Other
  6. 5.2 Global Heparin Sodium Injection Sales by Application
  7. 5.2.1 Global Heparin Sodium Injection Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Heparin Sodium Injection Sales by Application (2021-2032)
  9. 5.2.3 Global Heparin Sodium Injection Sales Market Share by Application (2021-2032)
  10. 5.3 Global Heparin Sodium Injection Revenue by Application
  11. 5.3.1 Global Heparin Sodium Injection Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Heparin Sodium Injection Revenue by Application (2021-2032)
  13. 5.3.3 Global Heparin Sodium Injection Revenue Market Share by Application (2021-2032)
6 Global Heparin Sodium Injection Sales by Region
  1. 6.1 Global Heparin Sodium Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Heparin Sodium Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Heparin Sodium Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Heparin Sodium Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Heparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Heparin Sodium Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Heparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Heparin Sodium Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Heparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Heparin Sodium Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Heparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Heparin Sodium Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Heparin Sodium Injection Revenue by Region
  1. 7.1 Global Heparin Sodium Injection Revenue by Region
  2. 7.1.1 Global Heparin Sodium Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Heparin Sodium Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Heparin Sodium Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Heparin Sodium Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Heparin Sodium Injection Revenue (2021-2032)
  8. 7.2.2 North America Heparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Heparin Sodium Injection Revenue (2021-2032)
  11. 7.3.2 Europe Heparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Heparin Sodium Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Heparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Heparin Sodium Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Heparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sichuan Deebio
  2. 8.1.1 Sichuan Deebio Company Information
  3. 8.1.2 Sichuan Deebio Business Overview
  4. 8.1.3 Sichuan Deebio Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sichuan Deebio Heparin Sodium Injection Product Portfolio
  6. 8.1.5 Sichuan Deebio Recent Developments
  7. 8.2 Shenzhen Hepalink
  8. 8.2.1 Shenzhen Hepalink Company Information
  9. 8.2.2 Shenzhen Hepalink Business Overview
  10. 8.2.3 Shenzhen Hepalink Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shenzhen Hepalink Heparin Sodium Injection Product Portfolio
  12. 8.2.5 Shenzhen Hepalink Recent Developments
  13. 8.3 Nanjing King-friend
  14. 8.3.1 Nanjing King-friend Company Information
  15. 8.3.2 Nanjing King-friend Business Overview
  16. 8.3.3 Nanjing King-friend Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nanjing King-friend Heparin Sodium Injection Product Portfolio
  18. 8.3.5 Nanjing King-friend Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Heparin Sodium Injection Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Changzhou Qianhong Bio-pharma
  26. 8.5.1 Changzhou Qianhong Bio-pharma Company Information
  27. 8.5.2 Changzhou Qianhong Bio-pharma Business Overview
  28. 8.5.3 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Product Portfolio
  30. 8.5.5 Changzhou Qianhong Bio-pharma Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Heparin Sodium Injection Product Portfolio
  36. 8.6.5 Baxter Recent Developments
  37. 8.7 Yino Pharma Limited
  38. 8.7.1 Yino Pharma Limited Company Information
  39. 8.7.2 Yino Pharma Limited Business Overview
  40. 8.7.3 Yino Pharma Limited Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Yino Pharma Limited Heparin Sodium Injection Product Portfolio
  42. 8.7.5 Yino Pharma Limited Recent Developments
  43. 8.8 Xinbai Pharmaceuticals
  44. 8.8.1 Xinbai Pharmaceuticals Company Information
  45. 8.8.2 Xinbai Pharmaceuticals Business Overview
  46. 8.8.3 Xinbai Pharmaceuticals Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Xinbai Pharmaceuticals Heparin Sodium Injection Product Portfolio
  48. 8.8.5 Xinbai Pharmaceuticals Recent Developments
  49. 8.9 Pharma Action
  50. 8.9.1 Pharma Action Company Information
  51. 8.9.2 Pharma Action Business Overview
  52. 8.9.3 Pharma Action Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pharma Action Heparin Sodium Injection Product Portfolio
  54. 8.9.5 Pharma Action Recent Developments
  55. 8.10 Opocrin
  56. 8.10.1 Opocrin Company Information
  57. 8.10.2 Opocrin Business Overview
  58. 8.10.3 Opocrin Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Opocrin Heparin Sodium Injection Product Portfolio
  60. 8.10.5 Opocrin Recent Developments
  61. 8.11 Dongying Tiandong Pharmaceutical
  62. 8.11.1 Dongying Tiandong Pharmaceutical Company Information
  63. 8.11.2 Dongying Tiandong Pharmaceutical Business Overview
  64. 8.11.3 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product Portfolio
  66. 8.11.5 Dongying Tiandong Pharmaceutical Recent Developments
  67. 8.12 Dongcheng Biochemicals
  68. 8.12.1 Dongcheng Biochemicals Company Information
  69. 8.12.2 Dongcheng Biochemicals Business Overview
  70. 8.12.3 Dongcheng Biochemicals Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dongcheng Biochemicals Heparin Sodium Injection Product Portfolio
  72. 8.12.5 Dongcheng Biochemicals Recent Developments
  73. 8.13 Changshan Biochemical
  74. 8.13.1 Changshan Biochemical Company Information
  75. 8.13.2 Changshan Biochemical Business Overview
  76. 8.13.3 Changshan Biochemical Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Changshan Biochemical Heparin Sodium Injection Product Portfolio
  78. 8.13.5 Changshan Biochemical Recent Developments
  79. 8.14 Bioibérica
  80. 8.14.1 Bioibérica Company Information
  81. 8.14.2 Bioibérica Business Overview
  82. 8.14.3 Bioibérica Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bioibérica Heparin Sodium Injection Product Portfolio
  84. 8.14.5 Bioibérica Recent Developments
  85. 8.15 Aspen Oss
  86. 8.15.1 Aspen Oss Company Information
  87. 8.15.2 Aspen Oss Business Overview
  88. 8.15.3 Aspen Oss Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Aspen Oss Heparin Sodium Injection Product Portfolio
  90. 8.15.5 Aspen Oss Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Heparin Sodium Injection Value Chain Analysis
  2. 9.1.1 Heparin Sodium Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Heparin Sodium Injection Production Mode & Process
  6. 9.2 Heparin Sodium Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Heparin Sodium Injection Distributors
  9. 9.2.3 Heparin Sodium Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst